Fidanza Cecilia Anna, Cassin Ramona, Cavallaro Francesca, Croci Giorgio Alberto, Rossi Dardanoni Francesca Gaia, Barcellini Wilma, Passamonti Francesco
Department of Oncology and Oncohematology, University of Milan, 20122 Milan, Italy.
Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Leuk Res Rep. 2025 Apr 24;23:100511. doi: 10.1016/j.lrr.2025.100511. eCollection 2025.
We report a rare case of vanishing bile duct syndrome (VBDS) associated with diffuse large B cell lymphoma (DLBCL). VBDS is an uncommon ductopenic disorder associated with various underlying conditions, for which timely treatment is crucial to prevent poor outcomes. Our patient received six cycles of R-CHOP chemotherapy every 21 days with halved doxorubicin and vincristine doses, and prophylactic intrathecal chemotherapy. A complete response of DLBCL and normalization of liver parameters were achieved upon completion of treatment. We conclude that, when VBDS is diagnosed, one can consider to urgently reach lymphoma remission even balancing the dose reduction of hepatotoxic drugs.
我们报告了一例罕见的与弥漫性大B细胞淋巴瘤(DLBCL)相关的胆管消失综合征(VBDS)。VBDS是一种与多种潜在疾病相关的罕见的胆管开放性疾病,及时治疗对于预防不良后果至关重要。我们的患者每21天接受六个周期的R-CHOP化疗,阿霉素和长春新碱剂量减半,并接受预防性鞘内化疗。治疗完成后,DLBCL完全缓解,肝脏参数恢复正常。我们得出结论,当诊断出VBDS时,即使在平衡肝毒性药物剂量减少的情况下,也可以考虑紧急实现淋巴瘤缓解。